跳至主要内容
临床试验/NCT02822170
NCT02822170已完成不适用

A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU

University of Vermont1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2016年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
4
试验地点
1
主要终点
6-minute walk distance (6MWD)

研究概览

简要总结

The purpose of this small pilot study is to refine a combined intervention of IV amino acids and cycle ergometry in critically ill patients, and to gather preliminary data, before proceeding with a larger multi-center RCT. A total of 10 patients will receive the combined intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •>=18 years old
  • •Requiring mechanical ventilation or high flow nasal cannula (HFNC) with actual or expected total duration of mechanical ventilation or HFNC >48 hours
  • •Expected ICU stay >4 days after enrollment (to permit adequate exposure to the proposed intervention)

排除标准

  • •>120 continuous hours of mechanical ventilation or HFNC before enrollment
  • •Expected death or withdrawal of life-sustaining treatments within 7 days from enrollment
  • •No expectation for any nutritional intake within the subsequent 72 hours
  • •Severe chronic liver disease (MELD score >20) or acute fulminant hepatitis.
  • •Documented allergy to the amino acid intervention
  • •Not ambulating independently prior to ICU admission (use of gait aid permitted)
  • •Pre-existing primary systemic neuromuscular disease (e.g. Guillain Barre)
  • •Neuromuscular blocker infusion (eligible once infusion discontinued if other inclusion criteria met)
  • •Pre-existing intracranial or spinal process affecting motor function
  • •Pre-existing cognitive impairment or language barrier that prohibits outcomes assessment
  • •Lower extremity impairments that prevent cycling (e.g. amputation, knee/hip injury)
  • •Weight >150kg
  • •Incarcerated

研究组 & 干预措施

IV amino acids and in-bed cycle ergometry

Experimental

Beginning within 96 hours of ICU admission, participants will receive the following combined intervention:

  1. IV amino acids (15% solution) delivered by continuous infusion, such that the total enteral and IV protein will be between 2.0-2.5 g/kg/day.
  2. In-bed cycle ergometry exercise delivered in 45-minute sessions 5 days per week according to a detailed specific protocol that includes a safety check and gradual increases in resistance if the participant is actively cycling.

干预措施: IV amino acids and in-bed cycle ergometry (Other)

结局指标

主要结局

6-minute walk distance (6MWD)

时间窗: 6MWD will be measured near the time that the particioant is being discharged from the hospital, up to 26 weeks after randomization.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Renee Stapleton

Associate Professor of Medicine

University of Vermont

研究点 (1)

Loading locations...

相似试验